Baohuoside-1, a novel immunosuppressive molecule, inhibits lymphocyte activation in vitro and in vivo

Transplantation

Volumn 78, Issue 6, 2004, Pages 831-838

  Ma, Anlun ^a   Qi, Shijie ^a   Xu, Dasheng ^a   Zhang, Xiaochun ^a   Daloze, Pierre ^a   Chen, Huifang ^a,b  

^a NOTRE DAME HOSPITAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Activation and proliferation; Baohuoside 1; IL 2; IL 2 receptor; Immunosuppressant; Tacrolimus

Indexed keywords

BAOHUOSIDE 1; CALCIUM IONOPHORE; CD28 ANTIGEN; CD3 ANTIGEN; CD69 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL DIVISION; DRUGS, CHINESE HERBAL; FLAVONOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KINETICS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MITOGENS; RATS; RATS, INBRED LEW; TETRADECANOYLPHORBOL ACETATE;

EID: 4644269466     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000137786.56231.41     Document Type: Article

References (22)

1. Flanagan WM, Corthesy B, Bram RJ, et al. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 1991; 352: 803.
2. Rivora P, Mascarell L, Truffa-Bachi P. The impact of immunosuppressive drugs on the analysis of T-cell activation. Curr Med Chemistry 2000; 7: 673.
3. Ma A, Chen H. New small molecule immunosuppressive agents in transplantation. Curr Drug Targets Cardiovasc Haematol Disord 2002; 2: 153.
4. Liang HR, Vuorela P, Vuorela H, et al. Isolation and immunomodulatory effect of flavonol glycosides from Epimedium hunanense. Planta Med 1997; 63: 316.
5. Li SY, Teh BS, Seow WK, et al. Effects of the plant flavonoid baohuoside-1 on cancer cell in vitro. Cancer Lett 1990; 53: 175.
6. Li SY, Ping G, Geng L, et al. Immunopharmacology and toxicology of the plant flavonoid baohuoside-1 in mice. Int J Immunopharmacol 1994; 16: 227.
7. Vu MD, Qi S, Wang X, et al. Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts. Transplantation 2003; 75: 1455.
8. Chen H, Wu J, Xu D, et al. Reversal of ongoing heart, kidney and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin. Transplantation 1993; 56: 661.
9. Liu J, Albers MW, Wandless TJ, et al. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 1992; 31: 3896.
10. Tocci MJ, Matkovich DA, Collier KA, et al. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 1989; 143: 718.
11. D'Ambrosio D, Cantrell DA, Frati L, et al. Involvement of p21 ras activation in T-cell CD79 expression. Eur J Immunol 1994; 24: 616.
12. Su B, Estela J, Hibi M, et al. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 1994; 77: 727.
13. Brazelton TR, Morris RE. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide. Curr Opin Immunol 1996; 8: 710.
14. Chong AS, Rezai K, Gebel HM, et al. Effects of leflunomide and other immunosuppressive agents on T cell proliferation in vitro. Transplantation 1996; 61: 140.
15. Luo H, Chen H, Daloze P, et al. Anti-CD28 antibody- and IL-4-induced human T cell proliferation is sensitive to rapamycin. Clin Exp Immunol 1993; 94: 371.
16. Taylor PA, Lees CJ, Wilson JM, et al. Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions. Blood 2002; 100: 3400.
17. Dumont FJ, Staruch MJ, Koprak SL, et al. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK506 and rapamycin. J Immunol 1990; 144: 251.
18. Barten MJ, Gummert JF, van Gelder T, et al. Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro. J Immunol Methods 2001; 253: 95.
19. Sigal NH, Dumont FJ. Cyclosporin A, FK506 and rapamycin: pharmacological probes of lymphocytes signal transduction. Annu Rev Immunol 1992; 10: 519.
20. Sehgal SN. Rapamycin (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 1998; 31: 335.
21. Terada N, Patel HR, Takase K, et al. Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proc Natl Acad Sci USA 1994; 91: 11477.
22. Kosuge H, Suzuki J, Gotoh R, et al. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible costimulator and cytotoxic T-lymphocyte antigen 4 pathway. Transplantation 2003; 75: 1374.